Elos Medtech Interim Report January 1 - June 30, 2017
High sales growth within Dental Implant Systems and increased market investments·Net sales for the first half of the year increased and amounted to SEK 296.5 M (292.0), corresponding to organic growth of 1.5%. ·Operating profit totalled SEK 26.8 M (28.0). ·Profit after net financial items amounted to SEK 15.5 M (21.3). Net financial items were negatively impacted by exchange rate differences of SEK - 6.7 M (-0.2). ·Profit after tax amounted to SEK 12.1 M (15.1), corresponding to SEK 2.00 (2.49) per share. ·Cash flow from operations was SEK 32.5 M (44.6) and